Skip to main content
Rozalina McCoy, MD, Endocrinology, Baltimore, MD

RozalinaGMcCoyMDMS(She/Her)

Endocrinology Baltimore, MD

Diabetes

Associate Professor of Medicine

Dr. McCoy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. McCoy's full profile

Already have an account?

  • Office

    670 W Baltimore St
    Baltimore, MD 21201
    Phone+1 410-706-7167

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 2012 - 2015
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2009 - 2012
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2009

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2023 - 2025
  • MN State Medical License
    MN State Medical License 2010 - 2023
  • WI State Medical License
    WI State Medical License 2020 - 2023
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Excessive HbA1c Testing among Patients with Controlled Non-insulin-requiring Type 2 Diabetes 
    Rochester, MN - 6/14/2014

Press Mentions

  • Thyroid Cancer Detections Due to More Screenings with GLP-1s
    Thyroid Cancer Detections Due to More Screenings with GLP-1sJanuary 28th, 2025
  • Increased Screening May Lead to Higher Thyroid Cancer Risk After GLP-1 Initiation
    Increased Screening May Lead to Higher Thyroid Cancer Risk After GLP-1 InitiationJanuary 23rd, 2025
  • More Thyroid Cancers Found After Starting GLP-1s: Researchers Think They Know Why
    More Thyroid Cancers Found After Starting GLP-1s: Researchers Think They Know WhyJanuary 23rd, 2025
  • Join now to see all

Professional Memberships